Tech Company Financing Transactions
Piedmont Pharmaceuticals Funding Round
CM Capital and private investors joined a $8.5 million Series B funding round for Piedmont Pharmaceuticals. The financing round closed on 11/12/2007.
Transaction Overview
Company Name
Announced On
11/12/2007
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series B
Investors
CM Capital (Lead Investor) (Andrew Jane)
Proceeds Purpose
The funding will help advance development of Piedmont Pharmaceuticals' pipeline, particularly the U.S. Phase III clinical trials of its patented, insecticide-free head lice treatment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
204 Muirs Chapel Rd. 200
Greensboro, NC 27410
USA
Greensboro, NC 27410
USA
Phone
Website
Email Address
Overview
Piedmont Pharmaceuticals is establishing industry leadership positions in the areas of parasitology and drug delivery technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roland Johnson
Chief Financial Officer
Michael Kelly
Chief Scientific Officer
Doug Hepler
VP - Bus. Development
Eric Barnett
VP - Marketing
Stan Cruitt
Browse more venture capital transactions:
Prev: 11/12/2007: Carnegie Speech venture capital transaction
Next: 11/12/2007: GigaFin Networks venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs